Former White Sox slugger and future Hall of Famer Frank Thomas, in New York for baseball’s first-year player draft, spoke to the media about the recent performance-enhancing drug controversy involving Biogenesis, flatly stating that PED users have no place in Cooperstown. Via ESPN’s Jerry Crasnick:
He said he has spoken with numerous Hall of Famers recently while taking part in a series of charity games, and they’re strongly opposed to players with links to performance-enhancing drugs gaining entry to Cooperstown.
“They say, ‘Hell, no,'” Thomas said. “They don’t want any of these guys in. These are super-superstars in my eyes, and they’re serious about it. I would suggest you get around the Johnny Benches, the Ozzie Smiths, the Dave Winfields and Mike Schmidts. Hold court with them and see how they feel. I’ve talked to them and it was eye-opening.
One of the Hall of Famers Thomas mentions, Mike Schmidt, previously said he would have used PEDs if he had the opportunity and would welcome PED users to the Hall.
Schmidt in 2009:
“I’d welcome him if he got elected to the Hall of Fame,” Schmidt said of A-Rod. “I always seem to walk down the middle of the fence. I understand the old, hard-line guys that use the words, `he cheated, he cheated.’ And the other guys that go, `It was a culture thing back then.’ If you played then, you would have been tempted, too. People in glass houses shouldn’t throw stones. I don’t want to get that wrong. We’ve all got some things in our closet.”
Schmidt once again indicated that he would have been tempted to use steroids if presented with the chance to take them when he was playing. He had said that before.
Confirming a report from Tuesday, the Diamondbacks officially signed right-hander Fernando Rodney to a one-year, $2.75 million contract on Friday. The 39-year-old stands to receive up to $4 million in incentives, per Jack MacGruder of FanRag Sports, with $250,000 kicking in when the veteran reaches 40, 50 and 60 appearances and $500,000 if he reaches 70.
Rodney came three games shy of the 70-appearance mark in 2016 during back-to-back stints with the Padres and Marlins. He put up a cumulative 3.44 ERA on the year, which effectively disguised the extreme split during his performances in San Diego and Miami. The Diamondbacks aren’t anywhere close to contending in 2017, but Rodney should stabilize the back end of their bullpen while providing Arizona GM Mike Hazen with a potential trade chip during next year’s deadline.
Hazen issued a statement following the signing:
With Fernando, we’re getting an established Major League closer and a veteran presence in the bullpen. It is helpful to have someone with his experience on the back end to slow the game down and get the final three outs.
The Cardinals have officially signed outfielder Dexter Fowler to a five-year, $82.5 million contract. Fowler will also get a full no-trade clause.
The Cardinals gave Fowler a bigger deal than many speculated he’d get, as some reports predicted he’d get something in the $52-72 million range. His skills, however — he’s a fantastic leadoff hitter who plays a premium defensive position — definitely earned him some major dough. Fowler hit .276/.393/.447 with 13 homers, 48 RBI and 13 steals over 125 games in 2016 for the World Series champion Cubs.
For the Cardinals, this will allow Matt Carpenter to move down to the middle of the batting order and will shift Randal Grichuk to left field. It also takes a prime piece from the Cardinals’ biggest rival. For their part, earlier this offseason the Cubs signed former Cardinal center fielder Jon Jay. So that’s fun.